PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 21, 2018The Lancet1,285 citationsOpen Access

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

CPChristopher ParkerNJNicholas D. JamesCBChris Brawley

Key Points

Key points are not available for this paper at this time.

Abstract

Cancer Research UK, UK Medical Research Council, Swiss Group for Clinical Cancer Research, Astellas, Clovis Oncology, Janssen, Novartis, Pfizer, and Sanofi-Aventis.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Parker et al. (2018) studied this question.

synapsesocial.com/papers/69d73733779571b57e48f6a1https://doi.org/10.1016/s0140-6736(18)32486-3
Ask AI
Helpful
Bookmark
Share
View Full Paper